Standard
Human epidermal growth factor receptor 2 status in urothelial bladder carcinoma : Frequency, genomic patterns and clinical significance. / Yu, Tianxi; Tao, Huiying; Lv, Wei; Liang, Ning; Cui, Xin; Sui, Xiaolong; Pan, Yu; Wu, Shuang; Xiang, Chongjun; Li, Yue; Zeng, Yuchen; Li, Conghui; Wang, Fei; Han, Peng; Wang, Wenting; Yu, Guohua; Lin, Chunhua.
In:
Clinical and Translational Discovery, Vol. 3, No. 5, e245, 2023.
Research output: Contribution to journal › Comment/debate › Research › peer-review
Harvard
Yu, T, Tao, H, Lv, W, Liang, N, Cui, X, Sui, X, Pan, Y, Wu, S, Xiang, C, Li, Y, Zeng, Y
, Li, C, Wang, F
, Han, P, Wang, W, Yu, G & Lin, C 2023, '
Human epidermal growth factor receptor 2 status in urothelial bladder carcinoma: Frequency, genomic patterns and clinical significance',
Clinical and Translational Discovery, vol. 3, no. 5, e245.
https://doi.org/10.1002/ctd2.245APA
Yu, T., Tao, H., Lv, W., Liang, N., Cui, X., Sui, X., Pan, Y., Wu, S., Xiang, C., Li, Y., Zeng, Y.
, Li, C., Wang, F.
, Han, P., Wang, W., Yu, G., & Lin, C. (2023).
Human epidermal growth factor receptor 2 status in urothelial bladder carcinoma: Frequency, genomic patterns and clinical significance.
Clinical and Translational Discovery,
3(5), [e245].
https://doi.org/10.1002/ctd2.245Vancouver
Yu T, Tao H, Lv W, Liang N, Cui X, Sui X et al.
Human epidermal growth factor receptor 2 status in urothelial bladder carcinoma: Frequency, genomic patterns and clinical significance.
Clinical and Translational Discovery. 2023;3(5). e245.
https://doi.org/10.1002/ctd2.245Author
Yu, Tianxi ; Tao, Huiying ; Lv, Wei ; Liang, Ning ; Cui, Xin ; Sui, Xiaolong ; Pan, Yu ; Wu, Shuang ; Xiang, Chongjun ; Li, Yue ; Zeng, Yuchen ; Li, Conghui ; Wang, Fei ; Han, Peng ; Wang, Wenting ; Yu, Guohua ; Lin, Chunhua. / Human epidermal growth factor receptor 2 status in urothelial bladder carcinoma : Frequency, genomic patterns and clinical significance. In: Clinical and Translational Discovery. 2023 ; Vol. 3, No. 5.
Bibtex
@article{6914518751804b90a531c0f4d7432962,
title = "Human epidermal growth factor receptor 2 status in urothelial bladder carcinoma: Frequency, genomic patterns and clinical significance",
keywords = "HER2, immunohistochemical staining, urothelial bladder carcinoma",
author = "Tianxi Yu and Huiying Tao and Wei Lv and Ning Liang and Xin Cui and Xiaolong Sui and Yu Pan and Shuang Wu and Chongjun Xiang and Yue Li and Yuchen Zeng and Conghui Li and Fei Wang and Peng Han and Wenting Wang and Guohua Yu and Chunhua Lin",
note = "Funding Information: We thank all the patients for their participation in the study. W.L. was funded by the China Scholarship Council (CSC). ",
year = "2023",
doi = "10.1002/ctd2.245",
language = "English",
volume = "3",
journal = "Clinical and Translational Discovery",
issn = "2768-0622",
publisher = "Wiley Open Access",
number = "5",
}
RIS
TY - JOUR
T1 - Human epidermal growth factor receptor 2 status in urothelial bladder carcinoma
T2 - Frequency, genomic patterns and clinical significance
AU - Yu, Tianxi
AU - Tao, Huiying
AU - Lv, Wei
AU - Liang, Ning
AU - Cui, Xin
AU - Sui, Xiaolong
AU - Pan, Yu
AU - Wu, Shuang
AU - Xiang, Chongjun
AU - Li, Yue
AU - Zeng, Yuchen
AU - Li, Conghui
AU - Wang, Fei
AU - Han, Peng
AU - Wang, Wenting
AU - Yu, Guohua
AU - Lin, Chunhua
N1 - Funding Information:
We thank all the patients for their participation in the study. W.L. was funded by the China Scholarship Council (CSC).
PY - 2023
Y1 - 2023
KW - HER2
KW - immunohistochemical staining
KW - urothelial bladder carcinoma
U2 - 10.1002/ctd2.245
DO - 10.1002/ctd2.245
M3 - Comment/debate
AN - SCOPUS:85175079509
VL - 3
JO - Clinical and Translational Discovery
JF - Clinical and Translational Discovery
SN - 2768-0622
IS - 5
M1 - e245
ER -
